Status:
COMPLETED
To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers
Lead Sponsor:
JW Pharmaceutical
Conditions:
Healthy
Eligibility:
All Genders
19-55 years
Phase:
PHASE1
Brief Summary
1. To evaluate the pharmacokinetic and pharmacodynamics characteristics after administration of Reference Drug or Test Drug in healthy volunteers under fasting conditions 2. To evaluate the safety and...
Detailed Description
1. It is analyzed for subjects who receive scheduled clinical trial drugs according to the clinical trial plan, have no significant violations in comparative analysis, and have completed all scheduled...
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- Subjects does not meet the Inclusion Criteria
Key Trial Info
Start Date :
June 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05433844
Start Date
June 2 2022
End Date
September 14 2022
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center, Seoul National University Hospital
Seoul, South Korea